Company Filing History:
Years Active: 2023-2024
Title: The Innovative Contributions of Jérôme Binet
Introduction
Jérôme Binet is a notable inventor based in Saint Denis en Val, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target ryanodine receptors. With a total of three patents to his name, Binet's work is paving the way for advancements in medical treatments.
Latest Patents
Binet's latest patents focus on pharmaceutical compositions that comprise a ryanodine receptor modulator. One of his notable inventions is a modified-release pharmaceutical composition that includes 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate, along with a pharmaceutically-acceptable excipient. This invention outlines methods for treating various conditions associated with ryanodine receptors, including cardiac disorders, musculoskeletal diseases, cancer-related muscle weakness, malignant hyperthermia, and diabetes.
Career Highlights
Jérôme Binet is currently associated with Armgo Pharma, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving health outcomes through targeted therapies.
Collaborations
Binet collaborates with esteemed colleagues such as Eugene E Marcantonio and Mette Uhre Anby. These partnerships enhance the research and development efforts at Armgo Pharma, Inc., contributing to the advancement of pharmaceutical sciences.
Conclusion
Jérôme Binet's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to improving medical treatments. His work continues to influence the industry and offers hope for patients with various health conditions.